International Kidney Cancer Collaboration with Leadership from Philadelphia - Takeaways - MDSpire

International Kidney Cancer Collaboration with Leadership from Philadelphia

Kidney cancer is a growing global health problem, and both clinicians and policymakers need to prepare for a steep rise in the number of cases,” said Alexander Kutikov, MD, FACS, Chair of the Department of Urology at Fox Chase Cancer Center, and senior author of a landmark international study published in European Urology, which demonstrates that if current trends continue, kidney cancer cases could double by 2050

  • By

  • December 2, 2025

  • 3 min

Share

  • 1

    Kidney cancer cases could double by 2050, highlighting a growing global health issue according to a study led by Fox Chase Cancer Center.

  • 2

    The study emphasizes the need for prevention, early detection, and policy planning to address rising kidney cancer incidence.

  • 3

    Modifiable risk factors such as obesity, diabetes, and smoking are significant contributors to the expected increase in kidney cancer cases.

  • 4

    Fox Chase – Temple Urologic Institute aims to enhance genetic testing and survivorship models in response to projected kidney cancer trends.

  • 5

    The study published in European Urology reflects the collaboration and leadership of Fox Chase and Temple Health in kidney cancer research.

Original Source(s)

International Kidney Cancer Collaboration with Leadership from Philadelphia

  • by

  • December 2, 2025

Related Content

Correction: Study on the mechanism of 18β-glycyrrhetinic acid inhibiting the proliferation of renal cancer cells by inducing autophagy through the miR-27a-5p/LC3 axis

Integrative oncology along with systemic cancer therapies in advanced bladder and prostate cancer: metabolic optimization guiding the shift from palliative care to clinical remission – a case report

Axitinib-Pembrolizumab and Adverse Event Management in Patients With Advanced Renal Cell Carcinoma